ACADIA Pharmaceuticals announced last week that the Psychopharmacologic Drugs Advisory Committee, a committee that operates under the FDA, will review its New Drug Application (NDA) for NUPLAZID. Read More »

Bristol-Myers Squibb and Pfizer announced this week that the companies have agreed to a cooperative effort with Portola Pharmaceuticals to develop and commercialize andexanet alpha. Read More »

The American Journal of Pharmacy Benefits (AJPB) recently announced that it has officially launched its website, www.ajpb.com. Read More »

The U.S. Food and Drug Administration (FDA) has made a commitment to work on the backlogged list of generic drugs currently awaiting approval. Read More »

Merck announced this week that the Food and Drug Administration (FDA) has accepted its Biologics License Application for bezlotoxumab for review. Read More »

CVS Health Research Institute has released a study that shows substantial progress in specialty medication given to their patients who are enrolled in a pilot study that assesses Specialty Connect. Read More »

Pharmaceutical companies worldwide have joined together to appeal to governments to aid them in taking on what are called "superbugs."  Read More »

AstraZeneca announced this week that its product Lynparza has been granted Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA). Read More »

EMD Serono announced this week that Gary Zieziula has been named president and managing director of the biopharma company. Read More »

The NACDS and its partner Healthcare Ready are coming to the aid of those needing medical supplies and prescriptions all along the East Coast, which was recently buried in snow and ice by Winter Storm Jonas. Read More »

The ASHP has published a new guide that will help determine the proper doses of medication for obese patients. Read More »

The Centers for Medicare and Medicaid Services (CMS) confirmed last week a rule to restructure Medicaid rebate and reimbursement programs for prescription drugs. Read More »

AstraZeneca has joined with GlaxoSmithKline and Johnson & Johnson to collaborate with three world-class universities to start the Apollo Therapeutics Fund. Read More »

Keystone Peer Review Organization Inc. (KEPRO) announced this week that it has agreed to its continued use of InterQual on a long-term basis. Read More »

McKesson Pharmacy Systems & Automation (MPS&A) has announced the release of its new technological platform, the McKesson Clinical Programs Solution, which is designed to help pharmacists tailor wellness plans to patients with specific needs. Read More »

ACADIA Pharmaceuticals said on Monday that it has hired Dr. James "Randy" Owen to be its new senior vice president for clinical development and chief medical officer. Read More »

Pharmaca is set to incorporate Ultimate Software’s UltiPro, according to Ultimate Software. Read More »

Allegran has announced that the Food and Drug Administration (FDA) has approved Botox to treat lower limb spasticity in adults. Read More »

The Food and Drug Administration (FDA) recently approved Allegran’s supplemental new drug application (sNDA) that will allow the company to update its DALVANCE label. Read More »

Steven C. Anderson, president and CEO of the National Association of Chain and Drug Stores (NACDS), recently responded to the substantial changes to the Covered Outpatient Drugs Final Rule, which would base Medicaid pharmacy reimbursement for generic drugs on the average manufacturer price (AMP) model. Read More »